$815 Million is the total value of Parkman Healthcare Partners LLC's 99 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 56.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| THC | Sell | TENET HEALTHCARE CORP | $29,835,789 | +10.7% | 283,853 | -20.4% | 3.66% | -3.6% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $29,449,874 | -17.1% | 128,199 | -20.6% | 3.61% | -27.8% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $29,140,646 | -22.8% | 425,473 | -34.8% | 3.58% | -32.8% |
| New | COOPER COS INC | $28,956,583 | – | 285,399 | +100.0% | 3.55% | – | |
| SDGR | Buy | SCHRODINGER INC | $27,000,378 | +86.1% | 1,000,014 | +146.8% | 3.31% | +62.2% |
| LLY | New | ELI LILLY & CO | $24,985,741 | – | 32,117 | +100.0% | 3.07% | – |
| DXCM | Sell | DEXCOM INC | $23,809,936 | -15.0% | 171,665 | -23.9% | 2.92% | -25.9% |
| ABC | Sell | CENCORA INC | $23,789,936 | +12.6% | 97,905 | -4.8% | 2.92% | -1.9% |
| Sell | RXSIGHT INC | $21,273,243 | +2.8% | 412,432 | -19.6% | 2.61% | -10.4% | |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $18,678,502 | +17.0% | 784,811 | +6.3% | 2.29% | +2.0% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $18,198,682 | -1.4% | 131,951 | -5.8% | 2.23% | -14.1% |
| INSP | Sell | INSPIRE MED SYS INC | $17,437,297 | -17.4% | 81,183 | -21.7% | 2.14% | -28.1% |
| New | FORTREA HLDGS INC | $17,172,053 | – | 427,804 | +100.0% | 2.11% | – | |
| PODD | Buy | INSULET CORP | $15,588,659 | -19.0% | 90,949 | +2.6% | 1.91% | -29.4% |
| SILK | Buy | SILK RD MED INC | $15,551,793 | +132.5% | 848,897 | +55.7% | 1.91% | +102.5% |
| LBPH | Buy | LONGBOARD PHARMACEUTICALS IN | $14,971,910 | +477.6% | 693,144 | +61.2% | 1.84% | +403.3% |
| ABT | Sell | ABBOTT LABS | $13,831,172 | -19.8% | 121,689 | -22.4% | 1.70% | -30.2% |
| New | QIAGEN NV | $13,496,882 | – | 313,954 | +100.0% | 1.66% | – | |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $13,053,900 | +130.8% | 524,253 | +67.6% | 1.60% | +101.0% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $12,748,796 | +18.1% | 646,163 | +4.9% | 1.56% | +2.8% |
| APLT | Buy | APPLIED THERAPEUTICS INC | $12,612,388 | +269.4% | 1,854,763 | +82.0% | 1.55% | +221.6% |
| OSCR | New | OSCAR HEALTH INCcl a | $12,361,178 | – | 831,283 | +100.0% | 1.52% | – |
| EWTX | Buy | EDGEWISE THERAPEUTICS INC | $11,922,631 | +67.2% | 653,653 | +0.3% | 1.46% | +45.7% |
| KROS | Sell | KEROS THERAPEUTICS INC | $11,805,777 | -17.6% | 178,335 | -50.5% | 1.45% | -28.2% |
| HCA | New | HCA HEALTHCARE INC | $11,767,939 | – | 35,283 | +100.0% | 1.44% | – |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $11,470,788 | +26.8% | 729,230 | +30.0% | 1.41% | +10.4% |
| DAWN | Buy | DAY ONE BIOPHARMACEUTICALS I | $11,428,734 | +25.1% | 691,812 | +10.6% | 1.40% | +8.9% |
| BDX | Sell | BECTON DICKINSON & CO | $11,282,978 | -31.4% | 45,597 | -32.4% | 1.38% | -40.3% |
| MNKD | Sell | MANNKIND CORP | $10,898,890 | +19.8% | 2,405,936 | -3.7% | 1.34% | +4.4% |
| Sell | ARCELLX INC | $10,891,391 | +16.6% | 156,598 | -6.9% | 1.34% | +1.6% | |
| PCVX | Sell | VAXCYTE INC | $10,243,494 | -39.0% | 149,956 | -44.0% | 1.26% | -46.9% |
| STRO | Buy | SUTRO BIOPHARMA INC | $10,113,788 | +96.1% | 1,790,051 | +48.9% | 1.24% | +70.7% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $9,640,703 | -29.0% | 223,942 | -24.0% | 1.18% | -38.2% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $9,050,602 | +70.5% | 15,572 | +55.7% | 1.11% | +48.4% |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $8,519,977 | -15.1% | 529,520 | +4.9% | 1.04% | -26.0% |
| CSTL | Buy | CASTLE BIOSCIENCES INC | $8,138,087 | +5.6% | 367,408 | +2.9% | 1.00% | -8.0% |
| LIVN | New | LIVANOVA PLC | $8,111,300 | – | 145,000 | +100.0% | 1.00% | – |
| ANTM | New | ELEVANCE HEALTH INC | $7,863,141 | – | 15,164 | +100.0% | 0.96% | – |
| HAE | Buy | HAEMONETICS CORP MASS | $7,763,607 | +29.8% | 90,962 | +30.1% | 0.95% | +13.2% |
| TVTX | Sell | TRAVERE THERAPEUTICS INC | $7,466,518 | -18.5% | 968,420 | -4.9% | 0.92% | -29.0% |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $7,403,500 | +436.4% | 850,000 | +604.5% | 0.91% | +368.0% |
| Buy | DISC MEDICINE INC | $6,698,740 | +24.9% | 107,593 | +15.9% | 0.82% | +8.7% | |
| New | VENTYX BIOSCIENCES INC | $6,644,545 | – | 1,208,099 | +100.0% | 0.82% | – | |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $6,549,435 | – | 387,770 | +100.0% | 0.80% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $6,400,155 | – | 453,590 | +100.0% | 0.78% | – |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $6,133,982 | -42.6% | 141,499 | -33.1% | 0.75% | -50.0% |
| CVRX | Buy | CVRX INC | $6,047,359 | -19.9% | 332,090 | +38.4% | 0.74% | -30.2% |
| NARI | New | INARI MED INC | $6,013,717 | – | 125,338 | +100.0% | 0.74% | – |
| VCYT | Buy | VERACYTE INC | $5,630,679 | -13.8% | 254,092 | +7.1% | 0.69% | -24.9% |
| SLN | Buy | SILENCE THERAPEUTICS PLCads | $5,280,574 | +30.5% | 244,471 | +4.9% | 0.65% | +13.7% |
| ARVN | Sell | ARVINAS INC | $5,159,133 | -24.9% | 124,979 | -25.2% | 0.63% | -34.6% |
| Buy | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $5,076,796 | +2.5% | 101,071 | +23.2% | 0.62% | -10.7% | |
| RCUS | Buy | ARCUS BIOSCIENCES INC | $4,907,290 | +3.7% | 259,920 | +4.9% | 0.60% | -9.6% |
| PFMT | Buy | PERFORMANT FINL CORP | $4,877,754 | -1.3% | 1,659,100 | +4.9% | 0.60% | -14.1% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $4,836,526 | -63.7% | 69,892 | -62.5% | 0.59% | -68.4% |
| CRL | New | CHARLES RIV LABS INTL INC | $4,795,002 | – | 17,697 | +100.0% | 0.59% | – |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $4,733,380 | +10.3% | 101,119 | -16.2% | 0.58% | -4.0% |
| Sell | NEWAMSTERDAM PHARMA COMPANYordinary shares | $4,737,355 | +41.0% | 200,311 | -33.4% | 0.58% | +22.8% | |
| ATEC | New | ALPHATEC HLDGS INC | $4,642,928 | – | 336,688 | +100.0% | 0.57% | – |
| FLDM | Buy | STANDARD BIOTOOLS INC | $4,526,787 | +239.3% | 1,670,401 | +176.7% | 0.56% | +195.2% |
| CNC | New | CENTENE CORP DEL | $4,378,713 | – | 55,794 | +100.0% | 0.54% | – |
| AUGX | Buy | AUGMEDIX INC | $4,360,386 | -26.6% | 1,066,109 | +5.0% | 0.54% | -36.1% |
| AKYA | Buy | AKOYA BIOSCIENCES INC | $4,302,803 | +30.7% | 917,442 | +36.0% | 0.53% | +13.8% |
| QTRX | Buy | QUANTERIX CORP | $4,149,199 | +3.7% | 176,112 | +20.3% | 0.51% | -9.8% |
| LYRA | Sell | LYRA THERAPEUTICS INC | $3,994,764 | +1.0% | 642,245 | -14.9% | 0.49% | -12.0% |
| NRIX | New | NURIX THERAPEUTICS INC | $3,675,000 | – | 250,000 | +100.0% | 0.45% | – |
| MRUS | Sell | MERUS N V | $3,607,939 | -16.9% | 80,123 | -49.2% | 0.44% | -27.5% |
| Sell | NUVALENT INC | $3,589,903 | -18.5% | 47,808 | -20.1% | 0.44% | -29.1% | |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $3,307,389 | -6.8% | 266,510 | +4.9% | 0.41% | -18.8% |
| ELAN | New | ELANCO ANIMAL HEALTH INC | $3,275,227 | – | 201,181 | +100.0% | 0.40% | – |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $3,062,964 | -28.1% | 1,142,897 | -19.8% | 0.38% | -37.3% |
| CGEM | Sell | CULLINAN ONCOLOGY INC | $3,039,868 | -43.7% | 178,396 | -66.3% | 0.37% | -51.0% |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $2,910,648 | -37.2% | 66,332 | -49.1% | 0.36% | -45.3% |
| URGN | Buy | UROGEN PHARMA LTD | $2,762,760 | +4.9% | 184,184 | +4.9% | 0.34% | -8.6% |
| NKTX | New | NKARTA INC | $2,724,423 | – | 252,028 | +100.0% | 0.33% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $2,670,797 | – | 226,723 | +100.0% | 0.33% | – |
| INSM | Sell | INSMED INC | $2,523,958 | -46.0% | 93,032 | -38.3% | 0.31% | -52.9% |
| SIBN | Buy | SI-BONE INC | $2,501,025 | -18.1% | 152,781 | +5.0% | 0.31% | -28.6% |
| VKTX | New | VIKING THERAPEUTICS INC | $2,484,436 | – | 30,298 | +100.0% | 0.30% | – |
| ANNX | New | ANNEXON INC | $2,485,746 | – | 346,687 | +100.0% | 0.30% | – |
| TGTX | Sell | TG THERAPEUTICS INC | $2,358,143 | -32.8% | 155,039 | -24.5% | 0.29% | -41.5% |
| ABOS | Sell | ACUMEN PHARMACEUTICALS INC | $2,335,461 | +0.8% | 576,657 | -4.4% | 0.29% | -12.0% |
| EPIX | New | ESSA PHARMA INC | $2,136,891 | – | 251,695 | +100.0% | 0.26% | – |
| VYNE THERAPEUTICS INC | $2,138,163 | +31.8% | 696,470 | 0.0% | 0.26% | +14.4% | ||
| ETNB | Sell | 89BIO INC | $2,094,024 | -14.6% | 179,899 | -18.0% | 0.26% | -25.5% |
| RVPH | New | REVIVA PHARMACEUTCLS HLDGS I | $1,904,568 | – | 503,854 | +100.0% | 0.23% | – |
| CDMO | New | AVID BIOSERVICES INC | $1,809,911 | – | 270,136 | +100.0% | 0.22% | – |
| INZY | Buy | INOZYME PHARMA INC | $1,707,743 | +88.7% | 222,943 | +4.9% | 0.21% | +65.4% |
| ARDX | New | ARDELYX INC | $1,460,000 | – | 200,000 | +100.0% | 0.18% | – |
| CYTK | New | CYTOKINETICS INC | $1,413,418 | – | 20,160 | +100.0% | 0.17% | – |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $1,119,449 | +74.0% | 805,359 | +5.0% | 0.14% | +50.5% |
| Buy | SOPHIA GENETICS SAordinary shares | $1,034,787 | +9.9% | 209,896 | +4.9% | 0.13% | -4.5% | |
| BFLY | New | BUTTERFLY NETWORK INC | $810,000 | – | 750,000 | +100.0% | 0.10% | – |
| TKNO | Buy | ALPHA TEKNOVA INC | $784,935 | -25.4% | 296,202 | +4.9% | 0.10% | -35.1% |
| NVCR | New | NOVOCURE LTD | $781,500 | – | 50,000 | +100.0% | 0.10% | – |
| ETON | ETON PHARMACEUTICALS INC | $746,880 | -14.4% | 199,168 | 0.0% | 0.09% | -25.2% | |
| TELA | Sell | TELA BIO INC | $553,778 | -19.1% | 97,668 | -5.5% | 0.07% | -29.2% |
| New | THIRD HARMONIC BIO INC | $377,600 | – | 40,000 | +100.0% | 0.05% | – | |
| New | XERIS BIOPHARMA HOLDINGS INC | $222,494 | – | 100,676 | +100.0% | 0.03% | – | |
| Exit | ASLAN PHARMACEUTICALS LTDspon ads new | $0 | – | -110,658 | -100.0% | -0.01% | – | |
| IMUX | Exit | IMMUNIC INC | $0 | – | -102,256 | -100.0% | -0.02% | – |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -96,837 | -100.0% | -0.08% | – |
| Exit | TANGO THERAPEUTICS INC | $0 | – | -65,679 | -100.0% | -0.09% | – | |
| BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -253,717 | -100.0% | -0.10% | – |
| LQDA | Exit | LIQUIDIA CORPORATION | $0 | – | -101,767 | -100.0% | -0.17% | – |
| Exit | AMBRX BIOPHARMA INC | $0 | – | -87,678 | -100.0% | -0.18% | – | |
| Exit | STRUCTURE THERAPEUTICS INCsponsored ads | $0 | – | -38,678 | -100.0% | -0.22% | – | |
| Exit | SOMALOGIC INC | $0 | – | -890,099 | -100.0% | -0.32% | – | |
| CRSP | Exit | CRISPR THERAPEUTICS AGput | $0 | – | -50,000 | -100.0% | -0.44% | – |
| SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -119,417 | -100.0% | -0.49% | – |
| NEO | Exit | NEOGENOMICS INC | $0 | – | -237,762 | -100.0% | -0.54% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INC | $0 | – | -100,734 | -100.0% | -0.57% | – |
| LNTH | Exit | LANTHEUS HLDGS INC | $0 | – | -80,000 | -100.0% | -0.70% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -100,000 | -100.0% | -0.72% | – |
| HUM | Exit | HUMANA INC | $0 | – | -18,081 | -100.0% | -1.17% | – |
| MTD | Exit | METTLER TOLEDO INTERNATIONAL | $0 | – | -7,500 | -100.0% | -1.28% | – |
| QGEN | Exit | QIAGEN NV | $0 | – | -250,000 | -100.0% | -1.53% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -61,524 | -100.0% | -2.50% | – |
| COO | Exit | COOPER COS INC | $0 | – | -75,183 | -100.0% | -4.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 19 | Q2 2024 | 6.3% |
| XENON PHARMACEUTICALS INC | 19 | Q2 2024 | 3.3% |
| SCHRODINGER INC | 18 | Q2 2024 | 4.2% |
| MANNKIND CORP | 18 | Q2 2024 | 1.7% |
| INSULET CORP | 17 | Q2 2024 | 4.8% |
| AVID BIOSERVICES INC | 17 | Q2 2024 | 2.9% |
| ARCUS BIOSCIENCES INC | 17 | Q2 2024 | 2.1% |
| ACLARIS THERAPEUTICS INC | 16 | Q3 2023 | 10.0% |
| NATERA INC | 16 | Q3 2023 | 3.4% |
| SUTRO BIOPHARMA INC | 16 | Q2 2024 | 1.9% |
View Parkman Healthcare Partners LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| PLUS THERAPEUTICS, INC. | February 13, 2023 | 583,467 | 1.7% |
View Parkman Healthcare Partners LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-14 |
| N-PX | 2024-08-01 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Parkman Healthcare Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.